HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Tarek M. Aziz Rasheed A. Saad Dhruva Prakash Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aziz, T. M. Articles by Prakash, D. Search for Related Content PubMed PubMed Citation Articles by Aziz, T. M. Articles by Prakash, D. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2002;21:527-533
© 2002 Elsevier Science NL

The management of second primary lung cancers. A single centre experience in 15 years

Division of Thoracic Surgery, Hairmyres Hospital, East Kilbride, Scotland G75 8RJ, UK

Received 14 November 2001; received in revised form 28 December 2001; accepted 3 January 2002.

* Corresponding author. Tel.: +44-1355-584-661; fax: +44-1355-584-473
e-mail: letitia.evans{at}laht.scot.nhs.uk

Objective: In patients treated for an initial lung cancer, the cumulative risk of developing a second primary lung cancer is a recognised occurrence. This study reviews our experience in the clinical assessment and surgical management of second primary lung cancer (SPLC). Methods: Between 1985–1999 a series of 892 patients with primary carcinoma of lung underwent surgical resection with curative intent in our institution. Using criteria set out by Martini and Melamed (J Thorac Cardiovasc Surg 70 (1975) 606) we were able to identify 51 patients who had developed a SPLC identified as the first site of re-occurrence. Results: Forty-one patients developed a metachronous SPLC within a mean of 46±14 months of the first operation while ten patients had synchronous double lung cancer (six unilateral, four bilateral). The cumulative probability of cancer free interval for metachronous cancers was 39% at 3 years, 15% at 5 years and 2% at 10 years. There were three postoperative deaths among the metachronous cancers (7.5%) and there were no operative deaths among patients with synchronous cancers. The overall actuarial 5-year survival for all patients with SPLC was 38% with a median survival of 40 months (range 1–142 months). The actuarial 5-year survival for metachronous SPLC was 44%, median survival of 49 months (range 1–142 months), while the actuarial 5-years survival for synchronous SLPC was 10% with a median survival of 31 months (range 4–78 months). Conclusion: Aggressive assessment and surgical intervention is safe, effective and warranted in patients with a second lung primary cancer if they satisfy the usual criteria of operability after full assessment. This is true for patients with metachronous cancers, while patients with synchronous cancers tend to have worse prognosis. A long term follow-up policy after the initial resection of the primary lung cancer is recommended at intervals of 6 months for at least 3–5 years and then annually to enable the early detection of the second cancer.

Key Words: Lung cancer • Second lung primary cancer

This article has been cited by other articles:

				M. Riquet, A. Cazes, K. Pfeuty, U. D. Ngabou, C. Foucault, A. Dujon, and E. Banu Multiple Lung Cancers Prognosis: What About Histology? Ann. Thorac. Surg., September 1, 2008; 86(3): 921 - 926. [Abstract] [Full Text] [PDF]

				J. Furak, I. Trojan, T. Szoke, A. Wolfard, E. Nagy, I. Nemeth, L. Tiszlavicz, and G. Lazar Lung cancer as a second primary malignant tumor: prognostic values after surgical resection Interactive CardioVascular and Thoracic Surgery, February 1, 2008; 7(1): 50 - 53. [Abstract] [Full Text] [PDF]

				Y.-L. Chang, C.-T. Wu, and Y.-C. Lee Surgical treatment of synchronous multiple primary lung cancers: Experience of 92 patients J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 630 - 637. [Abstract] [Full Text] [PDF]

				D. Trousse, F. Barlesi, A. Loundou, A. M. Tasei, C. Doddoli, R. Giudicelli, P. Astoul, P. Fuentes, and P. Thomas Synchronous multiple primary lung cancer: An increasing clinical occurrence requiring multidisciplinary management J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1193 - 1200. [Abstract] [Full Text] [PDF]

				K. Kushibe, T. Kawaguchi, Y. Nishimoto, M. Takahama, T. Tojo, and S. Taniguchi Operative indications for lung cancer with satellite lesions. Asian Cardiovasc Thorac Ann, August 1, 2006; 14(4): 316 - 320. [Abstract] [Full Text] [PDF]

				V. Getman, E. Devyatko, E. Wolner, S. Aharinejad, and M. R. Mueller Fleece bound sealing prevents pleural adhesions Interactive CardioVascular and Thoracic Surgery, June 1, 2006; 5(3): 243 - 246. [Abstract] [Full Text] [PDF]

				C. S.J. Duchateau and M. P.M. Stokkel Second Primary Tumors Involving Non-small Cell Lung Cancer: Prevalence and Its Influence on Survival Chest, April 1, 2005; 127(4): 1152 - 1158. [Abstract] [Full Text] [PDF]

				W. J. Scott Metachronous lung cancer: the role of improved postoperative surveillance J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 633 - 635. [Full Text] [PDF]

				R. J. Battafarano, S. D. Force, B. F. Meyers, J. Bell, T. J. Guthrie, J. D. Cooper, and G. A. Patterson Benefits of resection for metachronous lung cancer J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 836 - 842. [Abstract] [Full Text] [PDF]

				D. Rice, H.-W. Kim, A. Sabichi, S. Lippman, J. J. Lee, B. Williams, A. Vaporciyan, W. R. Smythe, S. Swisher, G. Walsh, et al. The risk of second primary tumors after resection of Stage I nonsmall cell lung cancer Ann. Thorac. Surg., October 1, 2003; 76(4): 1001 - 1008. [Abstract] [Full Text] [PDF]

				B. Jeremic Second primary cancers occurring in patients with early stage non-small-cell lung cancer treated with radiation therapy alone Eur. J. Cardiothorac. Surg., December 1, 2002; 22(6): 1039 - 1040. [Full Text] [PDF]